Cardioprotective medication adherence in Western Australians in the first year after myocardial infarction: restricted cubic spline analysis of adherence-outcome relationships.

Scientific Reports
Melanie GreenlandFrank M Sanfilippo

Abstract

Adherence to cardioprotective medications following myocardial infarction (MI) is commonly assessed using a binary threshold of 80%. We investigated the relationship between medication adherence as a continuous measure and outcomes in MI survivors using restricted cubic splines (RCS). We identified all patients aged ≥65 years hospitalised for MI from 2003-2008 who survived one-year post-discharge (n = 5938). Adherence to statins, beta-blockers, renin angiotensin system inhibitors (RASI) and clopidogrel was calculated using proportion of days covered to one-year post-discharge (landmark date). Outcomes were 1-year all-cause death and major adverse cardiac events (MACE) after the landmark date. Adherence-outcome associations were estimated from RCS Cox regression models. RCS analyses indicated decreasing risk for both outcomes above 60% adherence for statins, RASI and clopidogrel, with each 10% increase in adherence associated with a 13.9%, 12.1% and 18.0% decrease respectively in adjusted risk of all-cause death (all p < 0.02). Similar results were observed for MACE (all p < 0.03). Beta-blockers had no effect on outcomes at any level of adherence. In MI survivors, increasing adherence to statins, RASI, and clopidogrel, but not b...Continue Reading

References

Nov 27, 1999·Australian and New Zealand Journal of Public Health·C D HolmanM S Hobbs
Jan 11, 2007·JAMA : the Journal of the American Medical Association·Jeppe N RasmussenDavid A Alter
Jan 8, 2009·The Annals of Pharmacotherapy·Bradley C MartinBetsy Lynn Sleath
Jun 17, 2009·Circulation·P Michael HoJohn S Rumsfeld
Jan 21, 2010·Statistics in Medicine·Loic Desquilbet, François Mariotti
Dec 9, 2010·Circulation. Cardiovascular Quality and Outcomes·Tom G BriffaMatthew Knuiman
May 19, 2011·Circulation. Cardiovascular Quality and Outcomes·Urania Dafni
Oct 4, 2012·JAMA : the Journal of the American Medical Association·Sripal BangaloreUNKNOWN REACH Registry Investigators
May 17, 2013·Diabetes, Obesity & Metabolism·S H HoldenC J Currie
May 25, 2013·Pharmacoepidemiology and Drug Safety·Anton Pottegård, Jesper Hallas
Aug 3, 2013·European Heart Journal·Rajiv ChowdhuryOscar H Franco
Nov 15, 2013·BMJ : British Medical Journal·Katie JonesUNKNOWN Guideline Development Group
Oct 1, 2014·European Heart Journal·Kumaran KolandaiveluDeepak L Bhatt
Oct 28, 2015·Circulation·Gregory A RothChristopher J L Murray
Nov 4, 2015·BMC Research Notes·Leigh MellishSallie-Anne Pearson
Aug 2, 2016·Heart, Lung & Circulation·Derek P ChewUNKNOWN NHFA/CSANZ ACS Guideline 2016 Executive Working Group:
Aug 5, 2016·Cardiovascular Therapeutics·Anthony S GunnellFrank M Sanfilippo
Aug 20, 2016·Journal of the American College of Cardiology·Sameer BansilalValentin Fuster
Mar 16, 2017·Lancet·Mark D HuffmanPablo Perel
Apr 25, 2017·European Journal of Preventive Cardiology·Liping DuDan Mei

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapies

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.